Interacting Drugs |
Fosamprenavir vs Antifungal Agents (Azole Derivatives, Systemic) |
Security Level |
 |
Mechanism |
Antifungal Agents (Azole Derivatives, Systemic): May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Antifungal Agents (Azole Derivatives, Systemic). |
Management |
Limit indinavir adult dose to 600 mg every 8 hours with itraconazole or ketoconazole. With ritonavir, limit ketoconazole adult dose to 200 mg/day. Limit fluconazole, itraconazole, and ketoconazole to 200 mg (adult dose) with tipranavir/ritonavir. |
Fosamprenavir vs Antifungal Agents (Azole Derivatives, Systemic)
Post Review about Fosamprenavir vs Antifungal Agents (Azole Derivatives, Systemic) Click here to cancel reply.
Other Interactions of Fosamprenavir
Other Interactions of Antifungal Agents (Azole Derivatives, Systemic)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.